BusinessALNYLAM PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Investors in Alnylam Pharmaceuticals, Inc. of the Firm’s Investigation into Possible Securities Law ViolationsBy Nasdaq OMXOct 25, 2016, 1:30 PM UTC
BusinessALNYLAM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman is Investigating Possible Securities Law Violations by Alnylam Pharmaceuticals, Inc. and OfficersBy Nasdaq OMXOct 6, 2016, 10:04 PM UTC